Skip to content
Subscriber Only

Glaxo Plaintiff Lawyers Settle Dispute Over $143 Million

Lawyers who won what may be a $2.3 billion settlement with GlaxoSmithKline Plc over its Avandia diabetes drug resolved their own fight over the allocation of more than $143 million in legal fees.

Eight lawyers on a court-appointed fee committee agreed to take a smaller portion of the fee fund after nine objectors challenged their payouts, a special master assigned to review the recommendations said in court papers made public Jan. 18 in federal court in Philadelphia. The fee committee had asked for 71 percent of the fund set aside by U.S. District Judge Cynthia Rufe for the Avandia cases before her.